|
LBX Pharmacy Chain Joint Stock Company is a China-based company engaged in pharmaceutical retail chain operation. The Company involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The Company also involves in wholesale and manufacture of drugs.
Number of employees : 29 164 people.
|
|
| 2020 | 2021 | Delta | Retail | 12 078.10 | 86.5% | 13 790.90 | 87.9% | +14.18% |
Wholesale | 1 762.76 | 12.6% | 1 785.42 | 11.4% | +1.29% |
Other | 125.86 | 0.9% | 119.37 | 0.8% | -5.16% |
CNY in Million |
|
|
| 2020 | 2021 | Delta | China | 13 966.70 | 100% | 15 695.70 | 100% | +12.38% |
CNY in Million |
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
448,601,481 |
204,062,252 |
45.5% |
0 |
0.0% |
45.5% |
|
|
Name | Equities | % | Zi Long Xie | 126,452,741 |
31.0% | EQT Partners AB | 99,415,997 |
24.4% | Aegon-Industrial Fund Management Co., Ltd. | 14,070,069 |
3.45% | Guotai Asset Management Co., Ltd. | 13,769,088 |
3.37% | China Merchants Fund Management Co., Ltd. | 12,798,591 |
3.14% | First Sentier Investors (Hong Kong) Ltd. | 12,576,191 |
3.08% | Xiu Lan Chen | 8,027,040 |
1.97% | JPMorgan Asset Management (Asia Pacific) Ltd. | 7,654,394 |
1.88% | Abu Dhabi Investment Authority (Investment Management) | 7,043,332 |
1.73% | Zhan Shi | 6,068,420 |
1.49% |
|
|
Name | Equities | % | Valuation |
HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO., LTD. |
6,300,000 |
4.00% |
15,675,849 USD |
|
Company contact information |
|
LBX Pharmacy Chain JSC 288 Xiangya Road Kaifu District Changsha, Hunan 410008 Phone : +86.731.84035189 Fax : +86.731.84035199 Web : http://www.lbxdrugs.com
|
|
|
Sector Retail - Drugs with Grocery
Connections : LBX Pharmacy Chain Joint Stock Company
|